NASDAQ
Entero Therapeutics, Inc. (ENTO) has a fcf yield of -75.70% as of Friday, May 29, 2026. This represents a 56.06% increase compared to its 12-month average of -172.26%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.